{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:33:51Z","timestamp":1740166431495,"version":"3.37.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T00:00:00Z","timestamp":1720742400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T00:00:00Z","timestamp":1720742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100011094","name":"Public Health Agency of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011094","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Inappropriate or overuse of antibiotic prescribing in primary care highlights an opportunity for antimicrobial stewardship (AMS) programs aimed at reducing unnecessary use of antimicrobials through education, policies and practice audits that optimize antibiotic prescribing. Evidence from the early part of the pandemic indicates a high rate of prescribing of antibiotics for patients with COVID-19. It is crucial to surveil antibiotic prescribing by primary care providers from the start of the pandemic and into its endemic stage to understand the effects of the pandemic and better target effective AMS programs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This was a matched pair population-based cohort study that used electronic medical record (EMR) data from the Canadian Primary Care Sentinel Surveillance Network (CPCSSN). Participants included all patients that visited their primary care provider and met the inclusion criteria for COVID-19, respiratory tract infection (RTI), or non-respiratory or influenza-like-illness (negative). Four outcomes were evaluated (a) receipt of an antibiotic prescription; (b) receipt of a non-antibiotic prescription; (c) a subsequent primary care visit (for any reason); and (d) a subsequent primary care visit with a bacterial infection diagnosis. Conditional logistic regression was used to evaluate the association between COVID-19 and each of the four outcomes. Each model was adjusted for location (rural or urban), material and social deprivation, smoking status, alcohol use, obesity, pregnancy, HIV, cancer and number of chronic conditions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The odds of a COVID-19 patient receiving an antibiotic within 30\u00a0days of their visit is much lower than for patients visiting for RTI or for a non-respiratory or influenza-like-illnesses (AOR\u2009=\u20090.08, 95% CI[0.07, 0.09] compared to RTI, and AOR\u2009=\u20090.43, 95% CI[0.38, 0.48] compared to negatives). It was found that a patient visit for COVID-19 was much less likely to have a subsequent visit for a bacterial infection at all time points.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Encouragingly, COVID-19 patients were much less likely to receive an antibiotic prescription than patients with an RTI. However, this highlights an opportunity to leverage the education and attitude change brought about by the public health messaging during the COVID-19 pandemic (that antibiotics cannot treat a viral infection), to reduce the prescribing of antibiotics for other viral RTIs and improve antibiotic stewardship.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13756-024-01434-0","type":"journal-article","created":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T08:03:56Z","timestamp":1720771436000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Understanding the impact of COVID-19 on antibiotic use in Canadian primary care: a matched-cohort study using EMR data"],"prefix":"10.1186","volume":"13","author":[{"given":"Rachael","family":"Morkem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenys","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Braden","family":"Knight","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina T.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Barber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,12]]},"reference":[{"key":"1434_CR1","unstructured":"Cecchini M, Langer J, Slawomirski L. Antimicrobial Resistance in G7 Countries and Beyond: Economic issues, Policies and Options for Action. Germany: OECD; 2015."},{"issue":"6","key":"1434_CR2","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1542\/peds.2011-1337","volume":"128","author":"AL Hersh","year":"2011","unstructured":"Hersh AL, Shapiro DJ, Pavia AT, Shah SS. Antibiotic prescribing in ambulatory pediatrics in the United States. Pediatrics. 2011;128(6):1053\u201361.","journal-title":"Pediatrics"},{"issue":"1","key":"1434_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14745\/ccdr.v46i01a01","volume":"46","author":"JA Leis","year":"2020","unstructured":"Leis JA, Born KB, Ostrow O, Moser A, Grill A. Prescriber-led practice changes that can bolster antimicrobial stewardship in community health care settings. Can Commun Dis Resp. 2020;46(1):1\u20135.","journal-title":"Can Commun Dis Resp."},{"key":"1434_CR4","unstructured":"Public Health Agency of Canada. Canadian Antimicrobial Resistance Surveillance System Report Update 2020. 2020. https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/drugs-health-products\/canadian-antimicrobial-resistance-surveillance-system-2020-report.html. Accessed 12 Sept 2023."},{"issue":"4","key":"1434_CR5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.14745\/ccdr.v48i04a06","volume":"48","author":"S Wong","year":"2022","unstructured":"Wong S, Rajapakshe S, Barber D, Patey A, Levinson W, Morkem R, Hurwitz G, Wintermute K, Leis JA. Antibiotic prescribing for respiratory tract infection across a national primary care network in 2019. Can Commun Dis Resp. 2022;48(4):157.","journal-title":"Can Commun Dis Resp."},{"issue":"9","key":"1434_CR6","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/cid\/ciaa1139","volume":"72","author":"T Kitano","year":"2021","unstructured":"Kitano T, Langford BJ, Brown KA, Pang A, Chen B, Garber G, Daneman N, et al. The association between high and unnecessary antibiotic prescribing: a cohort study using family physician electronic medical records. Clin Infect Dis. 2021;72(9):345-e351.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"1434_CR7","doi-asserted-by":"publisher","first-page":"765","DOI":"10.7326\/M16-1131","volume":"66","author":"M Silverman","year":"2017","unstructured":"Silverman M, Povitz M, Sontrop JM, Li L, Richard L, Cejic S, Shariff SZ. Antibiotic prescribing for nonbacterial acute upper respiratory infections in elderly persons. Ann Intern Med. 2017;66(11):765\u201374.","journal-title":"Ann Intern Med"},{"key":"1434_CR8","doi-asserted-by":"publisher","first-page":"E360","DOI":"10.9778\/cmajo.20190175","volume":"8","author":"KL Schwartz","year":"2020","unstructured":"Schwartz KL, Langford BJ, Daneman N, Chen B, Brown KA, McIsaac W, et al. Unecessary antibiotic prescribing in a Canadian primary care setting: a descriptive analysis using routinely colleted electronic medical record data. CMAJ Open. 2020;8:E360\u20139.","journal-title":"CMAJ Open"},{"key":"1434_CR9","doi-asserted-by":"publisher","first-page":"2326e32","DOI":"10.1128\/AAC.02176-12","volume":"57","author":"KA Brown","year":"2013","unstructured":"Brown KA, Khanafer N, Daneman N, Fisman DN. Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection. Antimicrob Agents Chemother. 2013;57:2326e32.","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"1434_CR10","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1093\/jac\/dku046","volume":"69","author":"LM Feazel","year":"2014","unstructured":"Feazel LM, Malhotra A, Perencevich EN, Kaboli P, Diekema DJ, Schweizer ML. Effect of antibiotic stewardship programmes on Clostridium difficile incidence: a systematic review and meta-analysis. J Antimicrob Chemother. 2014;69(7):1748\u201354. https:\/\/doi.org\/10.1093\/jac\/dku046.","journal-title":"J Antimicrob Chemother"},{"key":"1434_CR11","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.3201\/eid1211.060255","volume":"12","author":"RJ Glass","year":"2006","unstructured":"Glass RJ, Glass LM, Beyeler WE, Min HJ. Targeted social distancing design for pandemic influenza. Emerg Infect Dis. 2006;12:1671\u201381.","journal-title":"Emerg Infect Dis"},{"key":"1434_CR12","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.cmi.2021.10.013","volume":"28","author":"BD Knight","year":"2022","unstructured":"Knight BD, Shurgold J, Smith G, MacFadden DR, Schwartz KL, Daneman N, Gravel Topper D, Brooks J. Impact of COVID-19 on community antibiotic use in Canada: an ecological study. Clin Microbiol Infect. 2022;28:426\u201332.","journal-title":"Clin Microbiol Infect."},{"issue":"5","key":"1434_CR13","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3390\/antibiotics11050643","volume":"11","author":"A Weill","year":"2022","unstructured":"Weill A, Drouin J, Desplas D, Cuenot F, Spira RD, Zureik M. Outpatient use of drugs in France during the COVID-19 epidemic\u2014patients and providers characteristics and impact of the COVID-19 pandemic. Antibiotics (Basel). 2022;11(5):643.","journal-title":"Antibiotics (Basel)"},{"key":"1434_CR14","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1093\/cid\/ciab241","volume":"73","author":"JK Sluggett","year":"2021","unstructured":"Sluggett JK, Dinh YH, Wesselingh SL, Inacio MC, Caughey GE. National changes in outpatient systemic antibiotic use during the coronavirus disease 2019 pandemic in Australia. Clin Infect Dis. 2021;73:2150\u20132.","journal-title":"Clin Infect Dis"},{"key":"1434_CR15","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3390\/antibiotics10050591","volume":"10","author":"AZ Hussain","year":"2021","unstructured":"Hussain AZ, Paudyal V, Hadi MA. Impact of the COVID-19 pandemic on the prescribing patterns of first-line antibiotics in english primary care: a longitudinal analysis of national prescribing dataset. Antibiotics. 2021;10:591.","journal-title":"Antibiotics"},{"key":"1434_CR16","first-page":"e652e60","volume":"73","author":"LM King","year":"2021","unstructured":"King LM, Lovegrove MC, Shehab N, Tsay S, Budnitz DS, Geller AI, et al. Trends in U.S. outpatient antibiotic prescriptions during the COVID-19 pandemic. Clin Infect Dis. 2021;73:e652e60.","journal-title":"Clin Infect Dis"},{"key":"1434_CR17","doi-asserted-by":"publisher","first-page":"762e8","DOI":"10.1016\/j.cmi.2021.02.007","volume":"27","author":"N Zhu","year":"2021","unstructured":"Zhu N, Aylin P, Rawson T, Gilchrist M, Majeed A, Holmes A. Investigating the impact of COVID-19 on primary care antibiotic prescribing in North West London across two epidemic waves. Clin Microbiol Infect. 2021;27:762e8.","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"1434_CR18","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/j.cmi.2020.07.016","volume":"26","author":"BJ Langford","year":"2020","unstructured":"Langford BJ, So M, Raybardhan S, Leung V, Westwood D, MacFadden DR, Soucy JPR, Daneman N. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect. 2020;26(10):1622\u20139.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"1434_CR19","doi-asserted-by":"publisher","first-page":"E28","DOI":"10.9778\/cmajo.20140128","volume":"4","author":"J Queenan","year":"2016","unstructured":"Queenan J, Williamson T, Khan S, Drummond N, Garies S, Morkem R, Birtwhistle R. Representativeness of patients and providers in the Canadian Primary Care Sentinel Surveillance Network: a cross-sectional study. CMAJ Open. 2016;4(1):E28\u201332.","journal-title":"CMAJ Open"},{"key":"1434_CR20","unstructured":"Gamache P., Hamel D., Blaser C. Material and social deprivation index: a summary \u2013INSPQ. 2020. \nwww.inspq.qc.ca\/en\/publications\/2639."},{"issue":"4","key":"1434_CR21","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1370\/afm.1644","volume":"12","author":"T Williamson","year":"2014","unstructured":"Williamson T, Green ME, Birtwhistle R, et al. Validating the 8 CPCSSN case definitions for chronic disease surveillance in a primary care database of electronic health records. Ann Fam Med. 2014;12(4):367\u201372.","journal-title":"Ann Fam Med"},{"issue":"2","key":"1434_CR22","doi-asserted-by":"publisher","first-page":"E376","DOI":"10.9778\/cmajo.20200183","volume":"9","author":"R Vijh","year":"2021","unstructured":"Vijh R, Wong S, Grandy M, Peterson S, Ezzat A, Gibb AG, Hawkins NM. Identifying health failure in patients with chronic obstructive lung disease through the Canadian Primary Care Sentinel Surveillance Network in British Columbia: a case derivation study. CMAJ Open. 2021;9(2):E376\u201383.","journal-title":"CMAJ Open"},{"key":"1434_CR23","doi-asserted-by":"publisher","first-page":"16085","DOI":"10.1038\/npjpcrm.2016.85","volume":"26","author":"AJ Cave","year":"2016","unstructured":"Cave AJ, Davey C, Ahmadi E, Drummond N, Fuentes S, Kazemi-Bajestani SMR, Sharpe H, Tayler M. Development of a validated algorithm for the diagnosis of paediatric asthma in electronic medical records. NPJ Prim Care Respir. 2016;26:16085.","journal-title":"NPJ Prim Care Respir"},{"issue":"11","key":"1434_CR24","doi-asserted-by":"publisher","first-page":"ofab533","DOI":"10.1093\/ofid\/ofab533","volume":"8","author":"T Kitano","year":"2021","unstructured":"Kitano T, Brown KA, Daneman N, MacFadden DR, Langford BJ, Leung V, So M, Leung E, Burrows L, Manuel D, Bowdish DME, Maxwell CJ, Bronskill SE, Brooks JI, Schwartz KL. The impact of COVID-19 on outpatient antibiotic prescriptions in Ontario, Canada; an interrupted time series analysis. Open Forum Infect Dis. 2021;8(11):ofab533. https:\/\/doi.org\/10.1093\/ofid\/ofab533. PMID: 34805442; PMCID: PMC8601042.","journal-title":"Open Forum Infect Dis."},{"issue":"4","key":"1434_CR25","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3390\/antibiotics11040445","volume":"11","author":"N Schellack","year":"2022","unstructured":"Schellack N, Strydom M, Pepper MS, Herd CL, Hendricks CL, Bronkhorst E, Meyer JC, et al. Social media and COVID-19 \u2013 perceptions and public deceptions of ivermectin, colchicine and hydroxychloroquine: lessons for future pandemics. Antibiotics (Basel). 2022;11(4):445.","journal-title":"Antibiotics (Basel)"},{"issue":"8","key":"1434_CR26","doi-asserted-by":"publisher","first-page":"e0255992","DOI":"10.1371\/journal.pone.0255992","volume":"16","author":"E Stephenson","year":"2021","unstructured":"Stephenson E, Butt DA, Gronsbell J, Ji C, O\u2019Neill B, Crampton N, Tu K. Changes in the top 25 reasons for primary care visits during the COVID-19 pandemic in a high-COVID region of Canada. PLoS One. 2021;16(8):e0255992.","journal-title":"PLoS One."},{"key":"1434_CR27","doi-asserted-by":"publisher","first-page":"182e8","DOI":"10.1093\/cid\/ciy978","volume":"69","author":"DR MacFadden","year":"2019","unstructured":"MacFadden DR, Fisman DN, Hanage WP, Lipsitch M. The relative impact of community and hospital antibiotic use on the selection of extended spectrum beta-lactamase-producing Escherichia coli. Clin Infect Dis. 2019;69:182e8.","journal-title":"Clin Infect Dis."}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-024-01434-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-024-01434-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-024-01434-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T08:08:30Z","timestamp":1720771710000},"score":1,"resource":{"primary":{"URL":"https:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-024-01434-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,12]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1434"],"URL":"https:\/\/doi.org\/10.1186\/s13756-024-01434-0","relation":{},"ISSN":["2047-2994"],"issn-type":[{"type":"electronic","value":"2047-2994"}],"subject":[],"published":{"date-parts":[[2024,7,12]]},"assertion":[{"value":"21 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has received approval from the Health Sciences and Affiliated Teaching Hospitals Research Ethics Board (FMED-6785\u201321) and adheres to all relevant guidelines and regulations for research involving de-identified health data (Tri-Council Policy Statements on the Ethical Conduct for Research Involving Humans [TCPS2]).Any data included in the CPCSSN database was obtained under ethics approval, including waivers of individual patient informed consent for their de-identified data to be used for surveillance and research purposes, from each Practice Based Research and Learning Network\u2019s local Research Ethics Board (University of British Columbia, University of Alberta, University of Calgary, University of Manitoba, University of Western Ontario, University of Toronto, Queen\u2019s University, University of Ottawa, Bruy\u00e8re Research Institute, and Memorial University of Newfoundland).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"76"}}